• Citing low vaccine trust, experts warn of measles in Philippines fiercepharma
    December 11, 2018
    Since Sanofi disclosed that its dengue vaccine Dengvaxia can cause more serious infections in certain people, distrust in vaccines has mounted in the Philippines...
  • J&J, Merck chip in for $100M U.K. vaccine center fiercepharma
    December 11, 2018
    To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...
  • Panav Bio-Tech Introduces Classical Swine Fever expressbpd
    December 05, 2018
    Himmvac Hog Cholera (T/C) Vaccine by Panav Bio-Tech is the vaccine that is made using Bovine Kidney Cell culture and provides protection against the Hog cholera or classical swine fever
  • FluGen’s broadly protective flu vaccine clears phase 1 fiercepharma
    December 04, 2018
    Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains, vaccine effectiveness can be much lower.
  • NIH grants IDT 10-year vaccine manufacturing contract fiercepharma
    December 04, 2018
    IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
  • Most Bills Enacted Into Law Limit Vaccine Exemptions drugs
    November 30, 2018
    Most proposed bills in state legislatures from 2011 to 2017 sought to expand access to immunization exemptions, but the majority of bills enacted into law limited exemptions......
  • DNAtrix, Valo Therapeutics Enter Strategic R&D Pact contractpharma
    November 28, 2018
    DNAtrix and Valo Therapeutics entered an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's antigenic peptide technology. 
  • Protection against yellow fever provided by fractional-dose vaccination europeanpharmaceuticalreview
    November 28, 2018
    Researchers at Leiden University Medical Center have identified how fractional-dose yellow fever vaccinations protect against the condition for ten years…
  • Marken, RareChannels Announce Collaboration contractpharma
    November 27, 2018
    Marken announced a new collaboration with RareChannels, a global web-based reference which allows manufactures of rare disease therapies and their affiliates to find customized logistic solutions.
  • FDA takes action against Sanofi biospectrumasia
    November 20, 2018
    Philippines' Food and Drug Administration (FDA) has suspended the sale of the controversial Dengvaxia dengue vaccine for a year.
PharmaSources Customer Service